Paula and Bobby
Parents of Lillie
Myopathy, Congenital Non Progressive, with Moebius Sequence and Robin Sequence
What is Myopathy, Congenital Non Progressive, with Moebius Sequence and Robin Sequence?
Also known as Carey Fineman Ziter syndrome, this rare genetic syndrome presents with low muscle tone as well as the Moebius sequence of symptoms, Pierre-Robin sequence, distinct facial features and growth delay.
What gene changes cause Myopathy, Congenital Non Progressive, with Moebius Sequence and Robin Sequence?
Mutations in the MYMK gene are responsible for causing the syndrome.
It is inherited in an autosomal recessive pattern.
What are the main symptoms of Myopathy, Congenital Non Progressive, with Moebius Sequence and Robin Sequence?
The main symptoms of Carey Fineman Ziter syndrome affect multiple parts and systems of the body. The main symptoms include,
Low muscle tone (hypotonia)
Moebius sequence of symptoms- bilateral facial palsy present at birth with an impaired ability of the eye to move in an outward position- also known as ocular abduction
Pierre Robin complex of symptoms- a small jaw, the downward displacement of the tongue and a cleft palate.
Other possible symptoms associated with the syndrome include unique facial features, brain abnormalities and intellectual disability. Some of these symptoms may be the result of muscle weakness during the development of affected individuals or the consequence of brainstem anomalies.
How does someone get tested for Myopathy, Congenital Non Progressive, with Moebius Sequence and Robin Sequence?
The initial testing for Myopathy, Congenital Non Progressive, with Moebius Sequence and Robin Sequence can begin with facial analysis screening, through the FDNA Telehealth telegenetics platform, which can identify the key markers of the syndrome and outline the need for further testing. A consultation with a genetic counselor and then a geneticist will follow.
Based on this clinical consultation with a geneticist, the different options for genetic testing will be shared and consent will be sought for further testing.
What is FDNA Telehealth?
FDNA Telehealth is a leading digital health company that provides faster access to accurate genetic analysis.
With a hospital technology recommended by leading geneticists, our unique platform connects patients with genetic experts to answer their most pressing questions and clarify any concerns they may have about their symptoms.
Benefits of FDNA Telehealth
Our platform is currently used by over 70% of geneticists and has been used to diagnose over 250,000 patients worldwide.
FDNA Telehealth provides facial analysis and screening in minutes, followed by fast access to genetic counselors and geneticists.
Ease of Use
Our seamless process begins with an initial online diagnosis by a genetic counselor and follows by consultations with geneticists and genetic testing.
Accuracy & Precision
Advanced artificial intelligence (AI) capabilities and technology with a 90% accuracy rate for a more accurate genetic analysis.
Faster access to genetic counselors, geneticists, genetic testing, and a diagnosis. As fast as within 24 hours if required. Save time and money.
Privacy & Security
We guarantee the utmost protection of all images and patient information. Your data is always safe, secure, and encrypted.